Shalapour and colleagues have recently reported that IgA+ plasma cells associated with NASH-derived HCC have an immunosuppressive phenotype characterized by the expression of PD-L1 and IL-10 and that they inhibit CD8+ T-cell activation [86]. This evidence concerns the gene CD79A and hepatocellular carcinoma.